Evidence map›Paper›PMID 37724517›Full record

Observational studyHuman vaccines & immunotherapeutics2023

Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance.

Vanessa De Pace, Bianca Bruzzone, Valentina Ricucci, Nicola Calcavecchia, Giulia Guarona, Irene Giberti, Elisabetta Costa, Matilde Ogliastro, Barbara Galano, Nicola Nigro and 3 more

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Vanessa De PaceHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Bianca BruzzoneHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Valentina RicucciHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Nicola CalcavecchiaDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Giulia GuaronaDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Irene GibertiDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Elisabetta CostaDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Matilde OgliastroDepartment of Health Sciences, University of Genoa, Genoa, Italy.
Barbara GalanoHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Nicola NigroHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Daniele MurgiaMedicine Laboratory, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Luca NanniMedicine Laboratory, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Andrea OrsiHygiene Unit, San Martino Policlinico Hospital - IRCCS for Oncology and Neurosciences, Genoa, Italy.
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 anti-spike IgG production and protection from severe respiratory illness should be explored in greater depth after COVID-19 booster vaccination. This longitudinal observational retrospective study investigated the anti-spike IgG response elicited by the first, second and booster doses of BNT162b2 mRNA vaccine in healthcare workers (HCW) at San Martino IRCCS Policlinico Hospital (Genoa) up to the 12

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralBNT162 VaccineFollow-Up StudiesHealth PersonnelHumansImmunoglobulin GmRNA VaccinesRetrospective StudiesSeroepidemiologic StudiesAntibodies, ViralBNT162 VaccineImmunoglobulin GmRNA Vaccinesanti-spike IgG seroprevalenceBNT162b2 vaccineCOVID-19healthcare workersSARS-CoV-2

Identifiers

PMID37724517
PMCPMC10512804
OpenAlexW4386846267

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.